Market revenue in 2023 | USD 47.5 million |
Market revenue in 2030 | USD 82.4 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Paramagnetic |
Fastest growing segment | Paramagnetic |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Paramagnetic, Superparamagnetic |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Bayer AG, Guerbet, Bracco, Miltenyi Biotec |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mri contrast media agents market will help companies and investors design strategic landscapes.
Paramagnetic was the largest segment with a revenue share of 87.79% in 2023. Horizon Databook has segmented the South Korea mri contrast media agents market based on paramagnetic, superparamagnetic covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea accounted for nearly 27.8 MRI units per 1,000,000 people in 2018 as per data published by OECD, showcasing high availability of these technologies among APAC countries. However, the country lacks a registry for documenting hypersensitivity reactions associated with these technologies.
Nonetheless, research activities related to MRI contrast media in the country are anticipated to help overcome this and facilitate market growth. Identification of a link between genetics and response to MRI contrast agents by South Korean scientists is expected to promote the establishment of iodinated contrast media-related hypersensitivity reactions registry in the country.
In 2018, the South Korean Ministry of Food and Drug Safety (MFDS) banned 13 linear gadolinium-based contrast agents, which contained gadodiamide, gadopentetic acid, and gadoversetamide, due to the potential risks associated with this agent. This ban is anticipated to limit the growth of these contrast agents.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea mri contrast media agents market , including forecasts for subscribers. This country databook contains high-level insights into South Korea mri contrast media agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account